Patient No | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
Complete KD | Incomplete KD | |||||||||||
Age, ethnicity | Infant, Latin | Infant, Caucasian | Infant, Caucasian | Toddler, Caucasian | Toddler, Caucasian | Toddler, Caucasian | Child, Caucasian | Infant, Asian | Toddler, Caucasian | Toddler, Black | Adolescent, Caucasian | Adolescent, Caucasian |
Symptoms prior to diagnosis | ||||||||||||
Duration (days) | 6 | 4 | 5 | 5 | 7 | 5 | 4 | 7 | 7 | 4 | 7 | 7 |
Respiratory | No | No | No | No | Yes | No | No | No | No | Yes | No | No |
Gastrointestinal | No | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Neurological | No | Yes | No | Yes | No | No | Yes | Yes | No | Yes | No | No |
KD signs at diagnosis | ||||||||||||
Conjunctivitis | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes |
Erythema mouth/pharynx | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No | No |
Polymorphous rash | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes |
Lymphadenopathy | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Yes |
Erythema of the palms/soles | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | No |
Contact with SARS-CoV-2 case | No | No | No | No | No | No | No | No | No | Yes | No | Yes |
SARS-CoV-2 RT-PCR in respiratory sample/stools | NEG/ND | NEG/POS | NEG/NEG | NEG/NEG | NEG/ND | NEG/NEG | NEG/NEG | NEG/NEG | NEG/ND | POS/ND | POS/ND | POS/ND |
SARS-CoV-2 IgG | NEG | POS | NEG | NEG | NEG | POS | POS | NEG | NEG | POS | POS | POS |
CRP (normal <15 mg/L) | 184 | 73 | 46 | 42 | 33 | 165 | 173 | 128 | 133 | 229 | 276 | 241 |
PCT (normal <0.5 ng/mL) | 0.08 | 3.1 | 0.11 | 0.21 | 0.14 | 6.75 | 6.7 | 0.51 | 0.07 | 4.65 | 3.97 | 2.11 |
Ferritin (normal <120 ng/mL) | 114 | 358 | 66 | 450 | 96 | 67 | 604 | 219 | 142 | 563 | >2000 | 1424 |
ESR (normal <15 mm/hour) | 83 | 14 | 43 | 2 | 23 | 63 | 9 | 2 | 46 | 19 | 39 | 76 |
NT pro-BNP (normal <200 ng/L) | 1416 | 647 | 178 | 291 | 457 | 7994 | 4510 | 3628 | 344 | 4840 | 2930 | 5500 |
Platelet count (normal 150–400×109/L) | 449 | 129 | 373 | 129 | 509 | 296 | 149 | 249 | 456 | 170 | 117 | 76 |
Lymphopenia | No | Yes | Yes | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes |
Treatment | IVIG followed by IVIG+mPDN | IVIG+mPDN | IVIG | IVIG | IVIG | IVIG | IVIG+mPDN | IVIG+mPDN | IVIG followed by IVIG+mPDN | IVIG | mPDN | None |
Length of stay (days) | 5 | 6 | 5 | 2 | 3 | 4 | 8 | 12 | 8 | 10 | 3 | 6 |
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; IVIG, intravenous immunoglobulin; KD, Kawasaki disease; mPDN, methylprednisolone; ND, not done; NEG, negative; NT pro-BNP, N-terminal pro-brain natriuretic peptide; PCT, procalcitonin; POS, positive; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.